About Ardego Therapeutics
Ardego Therapeutics is a private company based in Gaithersburg, Maryland, incorporated in 2026 in Delaware. It has reported $50,000 raised in one offering on Form D since June 2026. Its chief executive is Ethan Mann.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 13, 2026 | Jun 3, 2026 | $50,000of $3.0M target | 1 | $50,000 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ardego Therapeutics's Form D filed Jun 3, 2026.
Beverly Packard
Co-Founder and Chief Science Officer, director
EM